Turning Point Therapeutics, Inc.
DelistedCIK 1595893fmd_10P46GY71MV07EMR2WZEYQ1J33Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2017 to Jun 30, 2022, 19 periods
Latest annual · FY2021
Millions- Total revenues
- 31
- Operating income
- (238)
- Net income
- (237)
- Free cash flow
- (156)
Latest quarter · Q2 FY2022
Millions- Total revenues
- 0
- Operating income
- (124)
- Net income
- (123)
- Free cash flow
- (107)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- n/m
Turning Point Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $30.8 million | $25 million | +23.3% | 10-K 2022-02-28 · proof |
| Operating income | -$238 million | -$161.8 million | 10-K 2022-02-28 · proof | |
| Net income | -$236.6 million | -$157.3 million | 10-K 2022-02-28 · proof | |
| Cash from operating activities | -$153.9 million | -$82.8 million | 10-K 2022-02-28 · proof | |
| Free cash flow | -$156.3 million | -$84.1 million | 10-K 2022-02-28 · proof |
- What was Turning Point Therapeutics, Inc.'s revenue in fiscal 2021?
- Turning Point Therapeutics, Inc. reported revenue of $30.8 million for fiscal 2021 (the year ended Dec 31, 2021), against $25 million the year before (+23.3%). Source: the 10-K filed with the SEC on Feb 28, 2022. SEC
- What was Turning Point Therapeutics, Inc.'s operating income in fiscal 2021?
- Turning Point Therapeutics, Inc. reported operating income of -$238 million for fiscal 2021 (the year ended Dec 31, 2021), against -$161.8 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2022. SEC
- What was Turning Point Therapeutics, Inc.'s net income in fiscal 2021?
- Turning Point Therapeutics, Inc. reported net income of -$236.6 million for fiscal 2021 (the year ended Dec 31, 2021), against -$157.3 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2022. SEC
- What was Turning Point Therapeutics, Inc.'s cash from operating activities in fiscal 2021?
- Turning Point Therapeutics, Inc. reported cash from operating activities of -$153.9 million for fiscal 2021 (the year ended Dec 31, 2021), against -$82.8 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2022. SEC
- What was Turning Point Therapeutics, Inc.'s free cash flow in fiscal 2021?
- Turning Point Therapeutics, Inc. reported free cash flow of -$156.3 million for fiscal 2021 (the year ended Dec 31, 2021), against -$84.1 million the year before. Source: the 10-K filed with the SEC on Feb 28, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1595893&period_type=annual&limit=5"Information only, not investment advice.